Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-003461
Filing Date
2025-02-03
Accepted
2025-02-03 16:09:45
Documents
87
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q twst-20241231.htm   iXBRL 10-Q 897319
2 EX-31.1 twst-20241231x10qxex311.htm EX-31.1 10613
3 EX-31.2 twst-20241231x10qxex312.htm EX-31.2 10418
4 EX-32.1 twst-20241231x10qxex321.htm EX-32.1 4880
5 EX-32.2 twst-20241231x10qxex322.htm EX-32.2 4577
11 10-Q twst-20241231_g1.jpg GRAPHIC 1195
  Complete submission text file 0001628280-25-003461.txt   6221857

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twst-20241231.xsd EX-101.SCH 42390
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT twst-20241231_cal.xml EX-101.CAL 66179
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT twst-20241231_def.xml EX-101.DEF 154469
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twst-20241231_lab.xml EX-101.LAB 566659
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twst-20241231_pre.xml EX-101.PRE 391130
90 EXTRACTED XBRL INSTANCE DOCUMENT twst-20241231_htm.xml XML 885891
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38720 | Film No.: 25582584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)